Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. COPD exacerbations went down by 51% in patients with ...

Doing targeted COPD case finding as part of NHS lung cancer checks could save £33m over the next decade, research has shown.

Fewer than 1 in 5 patients with COPD receive the recommended levels of care, with nearly 1 in 4 waiting more than 5 years to be diagnosed, research has shown. The new research, from lung charity ...

SMSbiotech, a San Diego–based leader in regenerative medicine, today announced the initiation of its first-in-human Phase 1 clinical trial for Chronic Obstructive Pulmonary Disease (COPD). This ...

Oxygen therapy for COPD is a treatment used to increase the oxygen in your lungs and bloodstream. Research suggests that people with chronic obstructive pulmonary disease (COPD) who use oxygen may ...

Sanofi’s plans to submit itepekimab to regulators for approval this year have been thrown into doubt after the Regeneron-partnered drug failed one of a pair of phase 3 chronic obstructive pulmonary ...

Researchers report that as many as 70% of people with chronic obstructive pulmonary disease (COPD) or asthma could be undiagnosed. They say that receiving a diagnosis and treatment can dramatically ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage to the airways. It typically refers to emphysema and chronic bronchitis.

Many patients who have excess mucous production experience complicating bronchiectasis, which can be documented by high-resolution computed tomography (CT) of the chest. In the past, patients who had ...

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by the misfolding and accumulation of the mutant variant of alpha-1 antitrypsin (AAT) within hepatocytes, which limits its ...

Medicare usually covers the cost of inhalers for people with asthma, COPD, or certain other conditions under Part D or Medicare Advantage (Part C) plans. With Medicare coverage, you may still have ...